Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer's disease
- 6 May 2013
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 115 (9) , 1693-1696
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Autosomal Recessive Causes Likely in Early-Onset Alzheimer DiseaseArchives of Neurology, 2012
- Role of Thrombophilia in Vascular Access Thrombosis Among Chronic Hemodialysis Patients in TunisiaTherapeutic Apheresis and Dialysis, 2011
- Age and apoE associations with complex pathologic features in Alzheimer's diseaseJournal of the Neurological Sciences, 2008
- Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's diseaseNeuroscience Letters, 2006
- Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE?Arquivos de Neuro-Psiquiatria, 2005
- Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's diseaseNeuroscience Letters, 2004
- Apolipoprotein E, Methylenetetrahydrofolate Reductase(MTHFR) Mutation and the Risk of Senile Dementia. An Epidemiological Study Using the Polymerase Chain Reaction(PCR) Method.Journal of Epidemiology, 2000
- Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer DiseaseArchives of Neurology, 1998
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathwayThe Lancet, 1991